Kapitallashuvning sof aktivlarga nisbati: Senseonics Holdings (SENS)

Senseonics Holdings - SENS emitenti grafik logotipi

Glyukoza monitoringi tizimlari ishlab chiquvchisi Senseonics Holdings (SENS) uchun bozor tendentsiyasi barqaror muhandislik xodimlari va hamkorlikdagi distribyutsiya modeliga asoslangan bo'lib, ushbu ko'rsatkich 5.48 darajasida turibdi. Biroq, bozor ulushi uchun kurash ulkan xarajatlarni talab qiladi, bu esa erkin pul oqimini yo'qqa chiqaradi. Vaziyat logistik uzilishlar va sanksiya to'siqlari bilan yanada murakkablashgan bo'lib, bu mahsulotlarning xorijiy bozorlarga kirib borishini sezilarli darajada sekinlashtirmoqda.

Senseonics Holdings Inc (SENS) - Balans qiymatiga nisbatan bozor qiymati 04.07.2022dan 29.10.2026gacha

senseonics.com (SENS) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- bozor qiymati va tahlilchilarning maqsadli prognozi:
Narx grafigi Eversense|SENS - Tahlilchilar median maqsadi
- kompaniyaning birjadagi kapitallashuv ko'rsatkichlari:
Bozor bahosi Senseonics Corp|SENS - Biznesning umumiy qiymati
- balans kapitallashuvi ko'rsatkichlari:
Bitta aksiya hisobiga balans qiymati Senseonics|SENS - Kompaniyaning buxgalteriya qiymati|Bozor kapitallashuvining balans qiymatiga nisbati senseonics.com|SENS - Kompaniya aktivlari
- kompaniyaning jami qarzi va likvidligi ko'rsatkichlari:
Qarzning xususiy kapitalga nisbati Senseonics Holdings|SENS - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning kapitalga nisbati Senseonics|SENS - Kompaniyaning jamlangan qarzlari|Qarzning balans kapitallashuviga nisbati Senseonics Corp|SENS - Uzoq muddatli majburiyatlar|Kompaniyaning qisqa muddatli qarzlari Senseonics
Kompaniyaning dastlabki tahlili:Senseonics Holdings
senseonics.com ishlab chiqargan mahsulot

Senseonics Holdings (SENS) kompaniyasining glyukoza monitoringi sektoridagi kengayish dinamikasi bozor kapitalizatsiyasining balans hisoboti bilan nisbatining o'zgarishida aks etgan bo'lib, bu ko'rsatkich joriy aksiya narxini sof aktivlar bilan solishtiradi. Ushbu koeffitsiyent kapitalga nisbatan bozor premiumini o'lchaydi va operatsion xarajatlar ortib borayotgan bir paytda, investorlarning R&D samaradorligiga hamda rahbariyatning texnologik ustunlikni bozor ulushiga aylantirish qobiliyatiga bo'lgan ishonchini namoyish etadi.

Raqobatdosh kompaniyalar

DexCom, Inc. (DXCM) - Bozor qiymatining balans qiymatiga nisbati|PEN - Balans qiymatiga nisbatan bozor kapitallashuvi|Kapitallashuvning sof aktivlarga nisbati NOVT|HAE (Haemonetics Corp) - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor kapitallashuvining balans qiymatiga nisbati INSP|PRCT (Procept) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati CNMD (CONMED Corporation)|pulsebiosciences.com (PLSE) - Bozor qiymatining balans qiymatiga koeffitsiyenti|INMD - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati PMI (Picard Medical Corp)|SRDX: Bozor kapitallashuvining balans qiymatiga nisbati|NeuroPace Medical (NPCE) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Tactile Systems Technology, Inc.|sanuwave.com - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati OM|ELMD - Bozor qiymatining balans qiymatiga koeffitsiyenti|LENSAR, Inc - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati AVITA Medical Inc RCEL|PROF: Kapitallashuvning sof aktivlarga nisbati|Baird Medical Investment - Bozor kapitallashuvining balans qiymatiga multiplikatori|EDAP: Bozor kapitallashuvining balans qiymatiga nisbati|APYX - Balans qiymatiga nisbatan bozor kapitallashuvi|ICCM (IceCure Medical Ltd.) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Pulmonx Corp. (LUNG)|Kapitallashuvning sof aktivlarga nisbati TELA (TELA Bio, Inc.)|CTSO (cytosorbents.com) - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati Sensus Healthcare SRTS|ZYXI - Kapitallashuvning sof aktivlarga nisbati|electroCore Medical - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Vicarious Surgical Inc.|IINN: Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati ICU|IRIX (IRIDEX Corp) - Bozor kapitallashuvining balans qiymatiga nisbati|Intelligent Bio (INBS) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati XAIR|Kapitallashuvning sof aktivlarga nisbati Profusa, Inc PFSA|Bozor kapitallashuvining balans qiymatiga nisbati SSKN (STRATA Skin Sciences, Inc.)|Bozor kapitallashuvining balans qiymatiga nisbati GlucoTrack Inc. GCTK|NAOV - Bozor qiymatining balans qiymatiga nisbati|VERO: Bozor qiymatining balans qiymatiga nisbati|NUWE (CHF Solutions) - Kapitallashuvning sof aktivlarga nisbati|Aethlon Medical Corp - Balans qiymatiga nisbatan bozor qiymati|ASXC (Asensus Surgical Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti avinger.com AVGR|Bozor qiymatining balans qiymatiga nisbati biosig.com (BSGM)|Cutera Inc. (CUTR) - Bozor qiymatining xususiy kapitalga nisbati|Know Labs Corp - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Inari Medical Corp NARI|Nevro Corp. - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi ReShape Lifesciences RSLS|Silk Road Medical (SILK) - Bozor qiymatining balans qiymatiga nisbati